选择性抗发作药物抑制了微细胞的激活
Robert Jürgen Platow1,2, Sabrina Pommer1,2,3,4,5, Julia Brauer1,2
1Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
概括
抗发作药物 (ASM) 在耐药性模型中对微激活有不同的影响. 管阻断剂调节这种炎症,这表明ASM可能会影响患者的免疫反应.
科学领域:
- 神经免疫学
- 药理学
- 病研究
背景情况:
- 药物耐药性 (DRE) 存在重大治疗挑战.
- 在神经炎症中起着至关重要的作用,
- 抗发作药物 (ASM) 的抗炎性质尚未得到充分了解.
研究的目的:
- 研究ASM对微质激活的抗炎作用.
- 探索通道在微质炎症反应中的作用.
- 评估ASM对促炎性微质形态的影响.
主要方法:
- 使用脂多糖 (LPS) 或多酸:多酸 (多I:C) 激活了小鼠初级微细胞单种植物.
- 用各种ASM (例如,雪诺巴,氨酸) 和通道阻断剂 (例如,GS967,四毒素) 治疗微细胞.
- 通过RT-qPCR (Ptgs2,Tnf-α,Ifn-β) 和免疫细胞化学量化微细胞激活;还分析了通道表达.
主要成果:
- ASM对微质激活的作用有所不同.
- 塞诺巴马特独特地抑制了干扰素β (Ifn-β) 的诱导和减少了阿米形态.
- 电压通道Nav1. 2在微质表达,其水平与炎症反应相关;通道阻断剂调节微质激活.
结论:
- ASM 具有不同的降低微质激活和促炎形态的能力.
- 通道阻塞通过微质激活通路影响炎症.
- 需要进一步研究患者对ASM的免疫反应.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
512
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
512
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
446
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
446
Antiepileptic Drugs: GABAergic Pathway Potentiators
640
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
640
Antiepileptic Drugs: Calcium Channel Blockers
615
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
615
Antiepileptic Drugs: Sodium Channel Blockers
875
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
875
Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274


